Literature DB >> 14962184

Basal B-cell receptor signaling in B lymphocytes: mechanisms of regulation and role in positive selection, differentiation, and peripheral survival.

Ezequiel M Fuentes-Pananá1, Gregory Bannish, John G Monroe.   

Abstract

B-cell development is a highly ordered multistep process dependent upon signals generated by the pre-B and B-cell antigen receptor (BCR). BCR signals drive maturation of the B cell by integrating a number of parallel and sequential biological processes that result in generation of fully immunocompetent B cells. Among these biological processes are positive selection through several developmental checkpoints, negative selection of potentially self-reactive B cells, and activation of the mature B cell. In addition, recent studies have shown that developing and mature B cells rely on the constant activity of the BCR for their continued survival. Ligand (antigen)-dependent and -independent mechanisms of BCR signaling have been proposed, but their specific contributions to B-cell maturation and differentiation in the bone marrow and periphery are not completely clear. We discuss here a model, whereby ligand-independent basal BCR activity would be sufficient to trigger B-cell development through to the mature stage. However, long-term survival and formation of specific mature B-cell populations may be dependent on ligand-receptor interactions.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14962184     DOI: 10.1111/j.0105-2896.2004.0105.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  19 in total

Review 1.  The importance of natural IgM: scavenger, protector and regulator.

Authors:  Michael R Ehrenstein; Clare A Notley
Journal:  Nat Rev Immunol       Date:  2010-10-15       Impact factor: 53.106

Review 2.  Ligand-independent signaling during early avian B cell development.

Authors:  Kelly A Pike; Michael J H Ratcliffe
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  Chronic lymphocytic leukemia therapy: new targeted therapies on the way.

Authors:  Candida Vitale; Jan A Burger
Journal:  Expert Opin Pharmacother       Date:  2016-04-12       Impact factor: 3.889

4.  Role of the Igh intronic enhancer Eμ in clonal selection at the pre-B to immature B cell transition.

Authors:  Cheng Peng; Laurel A Eckhardt
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

5.  Structural optimization of an aptamer generated from Ligand-Guided Selection (LIGS) resulted in high affinity variant toward mIgM expressed on Burkitt's lymphoma cell lines.

Authors:  Hasan E Zümrüt; Sana Batool; Nabeela Van; Shanell George; Sanam Bhandari; Prabodhika Mallikaratchy
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-03-29       Impact factor: 3.770

6.  Enforced expression of the apoptosis inhibitor Bcl-2 ablates tolerance induction in DNA-reactive B cells through a novel mechanism.

Authors:  Ying-Hua Wang; Yi Yan; Jeffrey S Rice; Bruce T Volpe; Betty Diamond
Journal:  J Autoimmun       Date:  2011-04-01       Impact factor: 7.094

7.  Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages.

Authors:  Mileka R Gilbert; Nikki J Wagner; Shannon Z Jones; Amanda B Wisz; Jose R Roques; Kristen N Krum; Sang-Ryul Lee; Volker Nickeleit; Chrys Hulbert; James W Thomas; Stephen B Gauld; Barbara J Vilen
Journal:  J Immunol       Date:  2012-06-06       Impact factor: 5.422

8.  Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.

Authors:  Ranjana H Advani; Joseph J Buggy; Jeff P Sharman; Sonali M Smith; Thomas E Boyd; Barbara Grant; Kathryn S Kolibaba; Richard R Furman; Sara Rodriguez; Betty Y Chang; Juthamas Sukbuntherng; Raquel Izumi; Ahmed Hamdy; Eric Hedrick; Nathan H Fowler
Journal:  J Clin Oncol       Date:  2012-10-08       Impact factor: 44.544

9.  Effect of B-cell depletion on viral replication and clinical outcome of simian immunodeficiency virus infection in a natural host.

Authors:  Thaidra Gaufin; Melissa Pattison; Rajeev Gautam; Crystal Stoulig; Jason Dufour; Jeanne MacFarland; Daniel Mandell; Coty Tatum; Matthew H Marx; Ruy M Ribeiro; David Montefiori; Cristian Apetrei; Ivona Pandrea
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

10.  Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses.

Authors:  Seung-Chul Choi; Hongsheng Wang; Linjie Tian; Yousuke Murakami; Dong-Mi Shin; Francisco Borrego; Herbert C Morse; John E Coligan
Journal:  J Immunol       Date:  2012-12-24       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.